We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$155M
AUM Growth
+$4.64M
Cap. Flow
-$1.19M
Cap. Flow %
-0.77%
Top 10 Hldgs %
30.98%
Holding
150
New
9
Increased
28
Reduced
87
Closed
5

Top Buys

Rank Stock Value
1
BAY
BAYER AG SPONS ADR
BAY
+$651K
2
BIVV
Bioverativ Inc. Common Stock
BIVV
+$239K
3
COR icon
Cencora
COR
+$225K
4
AABA
Altaba Inc
AABA
+$213K
5
QVAL icon
Alpha Architect US Quantitative Value ETF
QVAL
+$199K

Top Sells

Rank Stock Value
1
VPL icon
Vanguard FTSE Pacific ETF
VPL
+$291K
2
PDCO
Patterson Companies, Inc.
PDCO
+$285K
3
USCI icon
US Commodity Index
USCI
+$277K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$260K
5
PNRA
Panera Bread Co
PNRA
+$220K

Sector Composition

Rank Sector Weight
1 Healthcare 22.78%
2 Financials 12.26%
3 Technology 11.93%
4 Industrials 10.01%
5 Consumer Staples 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CEF icon
26
Sprott Physical Gold and Silver Trust
CEF
$7.37B
$1.65M 1.07%
130,225
+7,950
+7% +$100K
NSC icon
27
Norfolk Southern
NSC
$74.7B
$1.56M 1.01%
11,775
+250
+2% +$30.4K
STT icon
28
State Street
STT
$50.6B
$1.56M 1.01%
16,291
-250
-2% -$23.3K
XOM icon
29
ExxonMobil
XOM
$636B
$1.48M 0.96%
18,032
-600
-3% -$47.6K
CHRW icon
30
C.H. Robinson
CHRW
$17.4B
$1.48M 0.95%
19,415
+225
+1% +$15.6K
BABA icon
31
Alibaba
BABA
$290B
$1.47M 0.95%
8,525
+400
+5% +$64.8K
AGN
32
DELISTED
Allergan plc
AGN
$1.44M 0.93%
7,043
-60
-0.8% -$14K
DGX icon
33
Quest Diagnostics
DGX
$25.8B
$1.36M 0.88%
14,538
+160
+1% +$17K
WBA
34
DELISTED
Walgreens Boots Alliance
WBA
$1.33M 0.86%
17,262
-455
-3% -$36.5K
AMGN icon
35
Amgen
AMGN
$206B
$1.33M 0.86%
7,138
-287
-4% -$50.9K
KO icon
36
Coca-Cola
KO
$376B
$1.31M 0.85%
29,208
-725
-2% -$33K
GE icon
37
GE Aerospace
GE
$370B
$1.28M 0.83%
11,027
+18
+0.2% +$2.18K
ETR icon
38
Entergy
ETR
$50.4B
$1.21M 0.78%
31,620
-100
-0.3% -$3.87K
RTX icon
39
RTX Corp
RTX
$286B
$1.17M 0.76%
16,073
-556
-3% -$41.1K
NVS icon
40
Novartis
NVS
$296B
$1.11M 0.72%
14,458
+279
+2% +$21.1K
VIG icon
41
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.09M 0.71%
11,551
-50
-0.4% -$4.67K
CME icon
42
CME Group
CME
$96.6B
$1.08M 0.7%
7,954
-75
-0.9% -$9.47K
BDX icon
43
Becton Dickinson
BDX
$45.1B
$1.07M 0.69%
5,578
-1,061
-16% -$206K
CERN
44
DELISTED
Cerner Corp
CERN
$1.03M 0.66%
14,405
+280
+2% +$18.6K
CNC icon
45
Centene
CNC
$30B
$1M 0.65%
20,742
+1,000
+5% +$43K
FLO icon
46
Flowers Foods
FLO
$1.5B
$1M 0.65%
53,310
-400
-0.7% -$7.1K
TECH icon
47
Bio-Techne
TECH
$11.2B
$977K 0.63%
32,328
-1,000
-3% -$29.7K
BIDU icon
48
Baidu
BIDU
$36.8B
$965K 0.62%
3,895
+75
+2% +$16.4K
BKNG icon
49
Booking.com
BKNG
$150B
$959K 0.62%
13,100
-175
-1% -$13.3K
UNP icon
50
Union Pacific
UNP
$172B
$947K 0.61%
8,170
-50
-0.6% -$5.36K
1
2
3 4 5

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Roberts, Glore & Co held 150 positions worth $155M, up 3.1% from $150M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Roberts, Glore & Co's Q3 2017 filing shows 9 new, 28 increased, 87 reduced and 5 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 4,073 shares worth $232K. The largest sale was Vanguard FTSE Pacific ETF, an estimated $291K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.

  • Roberts, Glore & Co's largest Q3 2017 buy was Bioverativ Inc. Common Stock: 4,073 shares worth $232K.
  • Roberts, Glore & Co added most to BAYER AG SPONS ADR in Q3 2017, an estimated $651K increase.
  • Roberts, Glore & Co's biggest Q3 2017 reduction was Vanguard FTSE Pacific ETF, cutting an estimated $291K.
  • Roberts, Glore & Co fully exited Patterson Companies, Inc. in Q3 2017, selling an estimated $285K.
  • Roberts, Glore & Co's ten largest holdings make up 31% of its $155M portfolio in Q3 2017.
  • Roberts, Glore & Co opened 9 new positions and closed 5 in Q3 2017.
  • Roberts, Glore & Co's portfolio value rose 3.1% quarter-over-quarter to $155M.

Based on Roberts, Glore & Co's 13F filing for Q3 2017, filed 8 Nov 2017.